Clinical trials - Press Releases

Date	Title	Company
17-Jun-2020	PTC Therapeutics Announces the Initiation of a Phase 2/3 Clinical Trial to Evaluate PTC299 for the Treatment of COVID-19	PTC Therapeutics
15-Jun-2020	New Phase 3 Data for TREMFYA®▼ (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, Show Consistent, High Levels of Skin Clearance Through Four Years in Adult Patients with Moderate to Severe Plaque Psoriasis	Janssen
13-Jun-2020	Subcutaneous Formulation of DARZALEX®▼(Daratumumab) Combination Resulted in Deep and Rapid Haematologic Responses and Improved Clinical Outcomes in the Treatment of Patients with Newly Diagnosed Light Chain (AL) Amyloidosis	Janssen Pharmaceutical Companies of Johnson & Johnson
12-Jun-2020	AstraZeneca to showcase leadership in treating type-2 diabetes and cardiorenal complications at ADA 2020	AstraZeneca
12-Jun-2020	AstraZeneca presents new data across continuum of care from its broad renal portfolio at ERA-EDTA 2020 Virtual Congress	AstraZeneca
12-Jun-2020	Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage	Amolyt Pharma
12-Jun-2020	Jazz Pharmaceuticals Announces the Poster Publication of Vyxeos® Liposomal (daunorubicin and cytarabine) Long-Term Phase 3 Data for Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukaemia at EHA Annual Congress	Jazz Pharmaceuticals plc
12-Jun-2020	ZZ Biotech Announces FDA Fast Track Designation for Stroke Program	ZZ Biotech, LLC
12-Jun-2020	Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress Pivotal AUTO1 study in adult ALL patients enrolling	Autolus Therapeutics plc
12-Jun-2020	Zelluna Immunotherapy raises funds to fully focus on developing allogeneic “off-the-shelf” TCR based Natural Killer (TCR-NK) cell therapies	Zelluna Immunotherapy
12-Jun-2020	RDIF and ChemRar deliver first batch of Avifavir antiviral drug to Russian hospitals	The Russian Direct Investment Fund
12-Jun-2020	FDA Approves Pfizer’s Oncology Supportive Care Biosimilar, NYVEPRIA™ (pegfilgrastim-apgf)	Pfizer Inc
12-Jun-2020	Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash	Sofinnova Partners
12-Jun-2020	Onyx Health Launch VR Learning Platform in Response to COVID-19	Onyx Health
12-Jun-2020	SCOTTISH LIFE SCIENCE COMPANY DEVELOPS COVID-19 ANTIBODY SCREENING TRIALS TO AID QUEST FOR VACCINE DEVELOPMENT	Arrayjet Limited
12-Jun-2020	NuCana Announces Re-Opening of Global Phase III Study of Acelarin Plus Cisplatin in Patients with Biliary Tract Cancer (NuTide:121)	NuCana
11-Jun-2020	Valmet to supply automation to a gas clean-up system at Viridor’s site in Scotland, UK	Valmet
11-Jun-2020	Clean cold experts explore how people in Africa can access COVID-19 vaccine	The University of Birmingham
11-Jun-2020	Intravacc and Versatope sign research service agreement to develop universal influenza vaccine based on OMV technology	Intravacc and Versatope
11-Jun-2020	First adjuvanted quadrivalent influenza vaccine receives EU approval Intended for medical, pharmaceutical industry and business media	Seqirus